Allakos (ALLK) Revenue & Revenue Breakdown
Allakos Revenue Highlights
00
Allakos Revenue by Period
Allakos Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | - |
Allakos Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $10.76M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | - |
Allakos Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RARE | Ultragenyx Pharmaceutical | $434.25M | $147.03M |
APLS | Apellis Pharmaceuticals | $366.28M | $176.57M |
BPMC | Blueprint Medicines | $249.38M | $128.18M |
SGMO | Sangamo Therapeutics | $176.23M | $356.00K |
HRTX | Heron Therapeutics | $127.04M | $36.02M |
RCUS | Arcus Biosciences | $117.00M | $48.00M |
CTMX | CytomX Therapeutics | $101.21M | $33.43M |
SPRO | Spero Therapeutics | $96.73M | $13.47M |
ARVN | Arvinas | $78.50M | $102.40M |
FATE | Fate Therapeutics | $63.53M | $6.77M |
CRBU | Caribou Biosciences | $34.48M | $3.46M |
RVMD | Revolution Medicines | $11.58M | - |
ATRA | Atara Biotherapeutics | $8.57M | $40.19M |
ASMB | Assembly Biosciences | $7.16M | $6.84M |
CRNX | Crinetics Pharmaceuticals | $4.01M | - |
ALLO | Allogene Therapeutics | $95.00K | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
NXTC | NextCure | - | - |
KURA | Kura Oncology | - | - |
ANNX | Annexon | - | - |
SANA | Sana Bio | - | - |
ALLK | Allakos | - | - |